Emily Yang

734 total citations
11 papers, 391 citations indexed

About

Emily Yang is a scholar working on Molecular Biology, Insect Science and Business and International Management. According to data from OpenAlex, Emily Yang has authored 11 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Insect Science and 2 papers in Business and International Management. Recurrent topics in Emily Yang's work include CRISPR and Genetic Engineering (6 papers), Insect symbiosis and bacterial influences (5 papers) and Innovation and Socioeconomic Development (2 papers). Emily Yang is often cited by papers focused on CRISPR and Genetic Engineering (6 papers), Insect symbiosis and bacterial influences (5 papers) and Innovation and Socioeconomic Development (2 papers). Emily Yang collaborates with scholars based in United States, China and Netherlands. Emily Yang's co-authors include Jackson Champer, Philipp W. Messer, Andrew G. Clark, Chen Liu, Esther Lee, Andrew J. Dannenberg, Jingxian Liu, Franz Fogt, Amin A. Nanji and S.M. Hossein Sadrzadeh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Genetics.

In The Last Decade

Emily Yang

10 papers receiving 388 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Yang United States 9 307 175 98 57 50 11 391
Bo Ji United States 7 275 0.9× 54 0.3× 87 0.9× 17 0.3× 26 0.5× 8 421
Xia Wu China 10 304 1.0× 51 0.3× 98 1.0× 105 1.8× 31 0.6× 17 418
Jun Zeng China 6 498 1.6× 24 0.1× 96 1.0× 17 0.3× 71 1.4× 11 612
You Wu China 11 136 0.4× 95 0.5× 22 0.2× 9 0.2× 92 1.8× 28 290
Françoise Dubois France 10 113 0.4× 89 0.5× 22 0.2× 5 0.1× 70 1.4× 26 347
Xiuli Lu China 12 130 0.4× 77 0.4× 26 0.3× 7 0.1× 104 2.1× 13 283
J F Charles France 11 343 1.1× 228 1.3× 53 0.5× 91 1.6× 111 2.2× 21 522
Yixia Wu China 11 81 0.3× 68 0.4× 41 0.4× 22 0.4× 48 1.0× 26 299
Rifu Xu China 14 183 0.6× 19 0.1× 186 1.9× 99 1.7× 28 0.6× 45 490
Christopher W. Brey United States 10 149 0.5× 46 0.3× 42 0.4× 17 0.3× 183 3.7× 13 317

Countries citing papers authored by Emily Yang

Since Specialization
Citations

This map shows the geographic impact of Emily Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Yang more than expected).

Fields of papers citing papers by Emily Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Yang. The network helps show where Emily Yang may publish in the future.

Co-authorship network of co-authors of Emily Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Yang. A scholar is included among the top collaborators of Emily Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Yang. Emily Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Du, Jie, Xuejiao Xu, Emily Yang, et al.. (2024). Germline Cas9 promoters with improved performance for homing gene drive. Nature Communications. 15(1). 4560–4560. 14 indexed citations
2.
Yosipovitch, Gil, Marjolein de Bruin‐Weller, Marni Wiseman, et al.. (2023). 41679 Lebrikizumab monotherapy improves quality of life through improvement in itch and sleep: Results from two Phase 3 trials in patients with moderate-to-severe atopic dermatitis. Journal of the American Academy of Dermatology. 89(3). AB61–AB61. 1 indexed citations
3.
Yang, Emily, et al.. (2022). Experimental demonstration of tethered gene drive systems for confined population modification or suppression. BMC Biology. 20(1). 119–119. 21 indexed citations
4.
Champer, Jackson, Emily Yang, Esther Lee, et al.. (2020). A CRISPR homing gene drive targeting a haplolethal gene removes resistance alleles and successfully spreads through a cage population. Proceedings of the National Academy of Sciences. 117(39). 24377–24383. 72 indexed citations
5.
Champer, Jackson, Esther Lee, Emily Yang, et al.. (2020). A toxin-antidote CRISPR gene drive system for regional population modification. Nature Communications. 11(1). 1082–1082. 87 indexed citations
6.
Champer, Jackson, Cindy Wen, Anisha Luthra, et al.. (2019). CRISPR Gene Drive Efficiency and Resistance Rate Is Highly Heritable with No Common Genetic Loci of Large Effect. Genetics. 212(1). 333–341. 27 indexed citations
7.
Champer, Jackson, Chen Liu, Emily Yang, et al.. (2019). Molecular safeguarding of CRISPR gene drive experiments. eLife. 8. 78 indexed citations
8.
Yang, Emily, et al.. (2009). Screening for porcine Calsarcin-1 interacting proteins by yeast two-hybrid system.. Zhongguo nongye Kexue. 42(2). 663–668. 1 indexed citations
9.
Wang, Heng, Shulin Yang, Emily Yang, et al.. (2007). NF-κB mediates the transcription of mouse calsarcin-1 gene, but not calsarcin-2, in C2C12 cells. BMC Molecular Biology. 8(1). 19–19. 8 indexed citations
10.
Nanji, Amin A., Emily Yang, Franz Fogt, S.M. Hossein Sadrzadeh, & Andrew J. Dannenberg. (1996). Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease.. Journal of Pharmacology and Experimental Therapeutics. 277(3). 1694–1700. 64 indexed citations
11.
Kashfi, Khosrow, et al.. (1994). Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants.. PubMed. 54(22). 5856–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026